Art

J-GLOBAL ID：201102245531569604   Reference number：11A0473533

Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes

ジペプチジルペプチダーゼ4阻害剤であるシタグリプチンは,2型糖尿病を有する日本人患者における収縮期血圧を下げる

Author (9)： OGAWA Susumu (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  OGAWA Susumu (Center for the Advancement of Higher Education, Tohoku Univ.) ,  ISHIKI Mikihito (Iwate Prefectural Takata Hospital) ,  NAKO Kazuhiro (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  OKAMURA Masashi (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  OKAMURA Masashi (United Centers for Advanced Res. and Translational Medicine, Tohoku Univ. Graduate School of Medicine) ,  SENDA Miho (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  MORI Takefumi (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku Univ. Graduate School of Medicine) ,  ITO Sadayoshi (Div. of Nephrology, Endocrinology and Vascular Medicine, Tohoku Univ. Graduate School of Medicine)
Material： Tohoku Journal of Experimental Medicine  (Tohoku J Exp Med)
Volume： 223  Issue： 2  Page： 133-135 (J-STAGE)  Publication year： 2011 
JST Material Number： G0649A  ISSN： 0040-8727  CODEN： TJEMAO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： proteinase inhibitor ,...
Semi thesaurus term： body mass index ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A0473533&from=J-GLOBAL&jstjournalNo=G0649A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for endocrine diseases  (GL05020S)

Substance index (1)： Sitagliptin

Reference (12)：

• ANDERSON, E. A. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension. 1992, 19, 621-627
• ANDERSON, E. A. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J. Clin. Invest. 1991, 87, 2246-2252
• FERREIRA, L. Effects of sitagliptin treatment on dysmetabolism, inflammation, and oxidative stress in an animal model of type 2 diabetes (ZDF rat). Mediators Inflamm. 2010, 2010, 592760
• GUTZWILLER, J. P. Glucagon-like peptide-1 is involved in sodium and water homeostasis in humans. Digestion. 2006, 73, 142-150
• GUTZWILLER, J. P. Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men. J. Clin. Endocrinol. Metab. 2004, 89, 3055-3061

Terms in the title (7)： ジペプチジルペプチダーゼ4 ,  阻害剤 ,  シタグリプチン ,  2型糖尿病 ,  日本人 ,  患者 ,  収縮期血圧